Harrington Cancer Center

Summary

Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Breast Cancer, Prostate Cancer, Lung Cancer, Head and Neck Cancers, Squamous Cell Carcinoma and other specialties. Harrington Cancer Center is involved with conducting 93 clinical trials across 106 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Harrington Cancer Center

Breast Cancer

sac-TMT + Pembrolizumab

for Breast Cancer

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.

Recruiting

2 awards

Phase 3

5 criteria

Genomic Testing

for Breast Cancer

The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.

Recruiting

1 award

N/A

3 criteria